$2.18
0.01 (+0.46%)
Sinovac Biotech Ltd. (NASDAQ:SVA)
CAPS Rating:
A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.
RSS Headlines
Fool UK